A carregar...
Fabry disease: recent advances in pathology, diagnosis, treatment and monitoring
BACKGROUND: In Fabry disease (α-galactosidase A deficiency) accumulation of Globotriaosylceramide (Gb3) leads to progressive organ failure and premature death. The introduction of enzyme replacement therapy (ERT) was the beginning of a new era in this disorder, and has prompted a broad range of rese...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2768700/ https://ncbi.nlm.nih.gov/pubmed/19818152 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1750-1172-4-21 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|